Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy. - Eslami M; Ermolaev N; Kronberger C; Schmid L; Poledniczek M; Gregshammer B; Kösters A; Alasti F; Kammerlander AA; Rettl R; Duca F; Binder C; et al. (Scientific reports, 2026)